Related Experiment Video
Updated: Sep 29, 2026

Induction of an Isoelectric Brain State to Investigate the Impact of Endogenous Synaptic Activity on Neuronal Excitability In Vivo
Published on: March 31, 2016
Life-threatening hyperkalaemia following therapeutic barbiturate coma
Christopher J S Cairns1, Benjamin Thomas, Stephen Fletcher
1Intensive Care Unit, Royal North Shore Hospital, St. Leonards, Sydney NSW, 2065, Australia.
Objective:
To report the occurrence of life-threatening hyperkalaemia following treatment with therapeutic thiopentone coma.
Setting:
The neurosurgical intensive care units of Royal North Shore Hospital and Liverpool Hospital, Sydney, Australia.
Patients:
Three patients treated with theraputic thiopentone coma. One patient with raised intracranial pressure secondary to a severe traumatic brain injury and two patients with refractory vasospasm secondary to subarachnoid haemorrhage. Two of the three patients developed hypokalaemia on starting thiopentone, which was resistant to potassium supplementation. All three patients developed severe hyperkalaemia during the recovery phase of coma. This was life-threatening in all three patients and fatal in one.
Conclusions:
Severe hypokalaemia refractory to potassium therapy may occur during therapeutic thiopentone coma. Severe rebound hyperkalaemia may occur after cessation of thiopentone infusion. Protocols for the management of patients with therapeutic barbiturate coma should recognise this potentially serious complication.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
06:58Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
Related Concept Videos
Sedatives and Hypnotics Drugs: Barbiturates
Diabetic Ketoacidosis ll: Pathophysiology
CNS Depressants: Barbiturates and Benzodiazepines
Diabetic Ketoacidosis l: Introduction
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Acute Respiratory Failure-III